✦ LIBER ✦

Mirtazapine has similar long-term efficacy and tolerability to citalopram and faster onset of action in the treatment of major depression

✍ Scribed by E. Leinonen; J. Skarstein; K. Behnke; H. Ångren; A.J. Schutte

Book ID: 119574691
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 148 KB
Volume: 10
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(00)80246-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.1.097 Escitalopram versus citalopram:

P.1.097 Escitalopram versus citalopram: More efficacious and well tolerated in long-term treatment of moderately depressed patients

✍ F. Menard; L. Colonna; H.F. Andersen 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Long-term tolerability and effectiveness

Long-term tolerability and effectiveness of duloxetine in the treatment of major depressive disorder

✍ David L. Dunner; Michael Wilson; Maurizio Fava; Susan Kornstein; Rodrigo Munoz; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 2 views

Efficacy of tianeptine vs placebo in the

Efficacy of tianeptine vs placebo in the long-term treatment (16.5 months) of unipolar major recurrent depression

✍ J. Dalery; V. Dagens-Lafont; C. de Bodinat 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

To compare the efficacy and acceptability of tianeptine vs placebo in the long-term treatment of unipolar major recurrent depression, 268 hospitalized and ambulatory patients meeting DSM III-R criteria for major depression with a 21-item Hamilton depression rating scale (HDRS) score >/= 17 and at le

Neuroendocrine, biochemical and pharmaco

Neuroendocrine, biochemical and pharmacokinetic effects of a long-term treatment with the selective serotonin reuptake inhibitor (SSRI) citalopram in major depressive disorder

✍ G. Nikisch; A. Czernik; A.A. Mathé; J. Diegmann; M. Amey; P. Baumann 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 149 KB

A 24-week, open-label extension to the A

A 24-week, open-label extension to the ACTivities of daily living and cognitION (ACTION) study: Long-term safety, tolerability and efficacy of a 13.3 mg/24 h rivastigmine patch in people with severe Alzheimer's disease

✍ Farlow, Martin; Grossberg, George; Sadowsky, Carl; Meng, Xiangyi; Somogyi, Moniq 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 51 KB

MAGNA CARTAThe Great CharterPreamble

📂 Fiction 🌐 English ⚖ 11 KB 👁 18 views